Axogen, inc. reports 2025 first quarter financial results

Alachua, fla. and tampa, fla., may 08, 2025 (globe newswire) -- axogen, inc. (nasdaq: axgn), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the first quarter ended march 31, 2025.
AXGN Ratings Summary
AXGN Quant Ranking